EUVIMEDEUVIMED entdecken
Crossref

Discovery and Synthesis of Selective Casein Kinase 1δ Degraders for Suppressing Oncogenic NRAS-Mutant Melanoma

Changfa Zhang, Yalei Wen, Jianqiao Yi, Xuan Wang, Junping Pei, Yalin Tu, Renwang Jiang iD, Tongzheng Liu, Xiaoyun Lu iD

Journal of Medicinal Chemistry · 2026

DOI: 10.1021/acs.jmedchem.6c01152 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Changfa Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Molecules and Druggability Assessment, International Cooperative Laboratory of Traditional Chinese Medicine Moderni…. Hauptthemen laut MEDLINE: Melanoma, Membrane Proteins, GTP Phosphohydrolases, Casein Kinase Idelta. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Major Project of Guangzhou National Laboratory, Science and Technology Planning Project of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Activating NRAS mutations occur in approximately 20% of melanomas but remain largely undruggable due to the lack of effective targeted therapies. We previously identified casein kinase 1δ (CK1δ) as a critical upstream regulator that stabilizes oncogenic NRAS mutants. However, no selective CK1δ inhibitors have advanced to clinical evaluation. Here, we report the discovery of 8u, a selective CK1δ degrader derived from PF-670462. Compound 8u potently degrades CK1δ in NRASQ61R melanoma cells (DC50 = 1.25 μM, Dmax = 74%) via the ubiquitin-proteasome system, sparing against the closely related isoform CK1α and CK1ε. CK1δ degradation induced by 8u leads to destabilization of NRASQ61R and attenuation of downstream signaling pathways. Furthermore, 8u elicited significant tumor regression (TGI = 58.9%) in an NRASQ61R xenograft model in vivo at 30 mg/kg. The studies establish targeted degradation of CK1δ as a promising therapeutic strategy for NRAS-mutant melanoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaMembrane ProteinsGTP PhosphohydrolasesCasein Kinase IdeltaAntineoplastic AgentsDrug DiscoveryProtein Kinase InhibitorsHumansAnimalsMutationMiceCell Line, TumorProteolysisXenograft Model Antitumor AssaysStructure-Activity Relationship

Stichwörter der Autor:innen

NRAS-mutant melanomacasein kinase 1δclinical resistancedegradation

Substanzen

NRAS protein, humanMembrane ProteinsGTP PhosphohydrolasesCasein Kinase IdeltaAntineoplastic AgentsProtein Kinase Inhibitors

Autor:innen und Institutionen

  • State Key Laboratory of Bioactive Molecules and Druggability Assessment, International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Discovery of Chinese Ministry of Education…
  • Department of Hematology, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou, Guangdong Province510317, China.

ORCID-Profile: Renwang Jiang, Xiaoyun Lu

Förderung

  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Major Project of Guangzhou National Laboratory
  • Science and Technology Planning Project of Guangdong Province
  • National Natural Science Foundation of China
  • Changjiang Scholar Program, Ministry of Education
  • Jinan University
  • Youth Science Fund Project

Zitieren

APA

Zhang, C., Wen, Y., Yi, J., Wang, X., Pei, J., Tu, Y., Jiang, R., Liu, T., & Lu, X. (2026). Discovery and Synthesis of Selective Casein Kinase 1δ Degraders for Suppressing Oncogenic NRAS-Mutant Melanoma. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c01152

Vancouver

Zhang C, Wen Y, Yi J, Wang X, Pei J, Tu Y, et al. Discovery and Synthesis of Selective Casein Kinase 1δ Degraders for Suppressing Oncogenic NRAS-Mutant Melanoma. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.6c01152

BibTeX
@article{Zhang2026,
  author = {Zhang, Changfa and Wen, Yalei and Yi, Jianqiao and Wang, Xuan and Pei, Junping and Tu, Yalin and Jiang, Renwang and Liu, Tongzheng and Lu, Xiaoyun},
  title = {Discovery and Synthesis of Selective Casein Kinase 1δ Degraders for Suppressing Oncogenic NRAS-Mutant Melanoma},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  doi = {10.1021/acs.jmedchem.6c01152}
}
Kostenlos starten →